These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17485285)

  • 1. Overcoming HIV-1 resistance to RNA interference.
    Boden D; Pusch O; Ramratnam B
    Front Biosci; 2007 May; 12():3104-16. PubMed ID: 17485285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1-specific RNA interference.
    Boden D; Pusch O; Ramratnam B
    Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs.
    Daniels SM; Sinck L; Ward NJ; Melendez-Peña CE; Scarborough RJ; Azar I; Rance E; Daher A; Pang KM; Rossi JJ; Gatignol A
    RNA Biol; 2015; 12(2):123-35. PubMed ID: 25668122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins.
    Boden D; Pusch O; Silbermann R; Lee F; Tucker L; Ramratnam B
    Nucleic Acids Res; 2004; 32(3):1154-8. PubMed ID: 14966264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter choice affects the potency of HIV-1 specific RNA interference.
    Boden D; Pusch O; Lee F; Tucker L; Shank PR; Ramratnam B
    Nucleic Acids Res; 2003 Sep; 31(17):5033-8. PubMed ID: 12930953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition.
    Das AT; Brummelkamp TR; Westerhout EM; Vink M; Madiredjo M; Bernards R; Berkhout B
    J Virol; 2004 Mar; 78(5):2601-5. PubMed ID: 14963165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HIV-1 replication by siRNA targeting conserved regions of gag/pol.
    Morris KV; Chung CH; Witke W; Looney DJ
    RNA Biol; 2005 Jan; 2(1):17-20. PubMed ID: 17132935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 escape from RNA interference.
    Boden D; Pusch O; Lee F; Tucker L; Ramratnam B
    J Virol; 2003 Nov; 77(21):11531-5. PubMed ID: 14557638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication.
    Martínez MA; Gutiérrez A; Armand-Ugón M; Blanco J; Parera M; Gómez J; Clotet B; Esté JA
    AIDS; 2002 Dec; 16(18):2385-90. PubMed ID: 12461411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of RNA interference in controlling HIV-1 replication.
    Soejitno A; Wihandani DM; Kuswardhani T
    Acta Med Indones; 2009 Oct; 41(4):215-21. PubMed ID: 20124619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
    Unwalla H; Banerjea AC
    Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attacking HIV-1 RNA versus DNA by sequence-specific approaches: RNAi versus CRISPR-Cas.
    Herrera-Carrillo E; Berkhout B
    Biochem Soc Trans; 2016 Oct; 44(5):1355-1365. PubMed ID: 27911718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference.
    Westerhout EM; ter Brake O; Berkhout B
    Retrovirology; 2006 Sep; 3():57. PubMed ID: 16948865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts.
    Adams M; Sharmeen L; Kimpton J; Romeo JM; Garcia JV; Peterlin BM; Groudine M; Emerman M
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3862-6. PubMed ID: 8171003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome.
    Westerhout EM; Ooms M; Vink M; Das AT; Berkhout B
    Nucleic Acids Res; 2005; 33(2):796-804. PubMed ID: 15687388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
    ter Brake O; Konstantinova P; Ceylan M; Berkhout B
    Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi as a treatment for HIV-1 infection.
    Rossi JJ
    Biotechniques; 2006 Apr; Suppl():25-9. PubMed ID: 16629384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of HIV replication using RNA interference against HIV-1 integrase.
    Lau TS; Li Y; Kameoka M; Ng TB; Wan DC
    FEBS Lett; 2007 Jul; 581(17):3253-9. PubMed ID: 17592732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference.
    Coburn GA; Cullen BR
    J Virol; 2002 Sep; 76(18):9225-31. PubMed ID: 12186906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.